Microbiotica develops microbiome-based medicines that use selected gut bacteria for the treatment of cancer and inflammatory bowel diseases.
Microbiotica has raised $47.9M in total funding. The most recent round was Series C. The last funding was announced in October 2026.
Microbiotica's investors include British Business Bank, Tencent, Seventure Partners, Cambridge Innovation Capital, IP Group.
Microbiotica is headquartered in Cambridge, United Kingdom.
Microbiotica develops microbiome-based medicines that use selected gut bacteria for the treatment of cancer and inflammatory bowel diseases.
Microbiotica is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Microbiotica — Funding & Investors." VCBacked, October 16, 2026, https://www.vcbacked.co/company/microbiotica. Accessed November 12, 2026.
VCBacked. (2026). Microbiotica — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/microbiotica
{{cite web |title=Microbiotica — Funding & Investors |url=https://www.vcbacked.co/company/microbiotica |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Microbiotica? Request a listing update